In early January, the U-M Michigan Translational Research and Commercialization for Life Sciences Program (MTRAC) held its Oversight Committee meeting where 16 finalists presented their proof-of-concept projects. The Oversight Committee, comprised of global biotech business experts and U-M leaders in translational science and tech transfer, selected 11 projects for funding including two from MCIRCC members:
- Advanced Hemodynamic Assessment and Monitoring Using Computer-Aided Analysis of ECG Signals - Ashwin Belle, Rodney Daniels and Kayvan Najarian
For a complete list of all 2015 MTRAC awardees, click here.
MTRAC provides mid-stage, translational research funding and resources to identify, nurture, and “fast forward” projects with a high potential for commercial success. This is MTRAC’s second year running its successful funding program, which saw 29 high-quality proposals submitted for consideration.
To find out more about MTRAC, click here.